CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema

Wang R.; Thomas J.; Batra R.; Biedermann T.; Theis F.; Eyerich S.; Eyerich K.

首页> 外文期刊>Experimental dermatology >CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema

【24h】

CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema

机译：CD23是对严重特征湿疹患者的IgE特异性免疫吸附的临床反应的生物标志物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Experimental dermatology》 |2019年第3期|共2页
作者
Wang R.; Thomas J.; Batra R.; Biedermann T.; Theis F.; Eyerich S.; Eyerich K.;
展开▼
作者单位

Tech Univ Munich Dept Dermatol &

Allergy Munich Germany;

Tech Univ Munich Munich Germany;

Helmholtz Ctr Munich Inst Computat Biol Neuherberg Germany;

Tech Univ Munich Dept Dermatol &

Allergy Munich Germany;

Helmholtz Ctr Munich Inst Computat Biol Neuherberg Germany;

Tech Univ Munich Munich Germany;

Tech Univ Munich Dept Dermatol &

Allergy Munich Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词
入库时间 2022-08-20 03:00:25

相似文献

外文文献
中文文献
专利

1. CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema [J] . Wang R., Thomas J., Batra R., Experimental dermatology . 2019,第3期

机译：CD23是对严重特征湿疹患者的IgE特异性免疫吸附的临床反应的生物标志物
2. Predicting treatment response to methotrexate in atopic dermatitis patients using clinical characteristics and serum biomarkers [J] . Ariens L., Thijs J., Bakker D., The Journal of investigative dermatology. . 2019,第9Suppla2期

机译：使用临床特征和血清生物标志物预测特应性皮炎患者对甲氨蝶呤的治疗反应
3. Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma [J] . Zhu Rui, Zheng Yanan, Dirks Nathanael. L., Pulmonary pharmacology & therapeutics . 2017,第期

机译：基于模型的临床药理学分析和暴露 - 中度至重度哮喘患者菌菌菌菌疗效和生物标志物的抗曝光关系
4. Machine Learning-powered Prediction of Recurrence in Patients with Non-small Cell Lung Cancer Using Quantitative Clinical and Radiomic Biomarkers [C] . Sehwa Moon, Dahim Choi, Ji-Yeon Lee, Medical Imaging Conference . 2020

机译：使用定量学习和放射生物标志物的机器学习技术预测非小细胞肺癌患者的复发
5. Evaluation of a potential novel biomarker & derivation of clinical prediction rules for severe influenza in emergency department patients. [D] . Chen, Kuan-Fu. 2010

机译：对急诊科患者中严重流感的潜在新生物标志物的评估和临床预测规则的推导。
6. Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience [O] . Silvia Ferrucci, Giovanni Casazza, Luisa Angileri, 2020

机译：Dupilumab治疗的重症特应性皮炎患者的临床反应和生活质量：单中心真实生活经验
7. 044 Cellular mechanism of action of IgE-specific immunoadsorption in treatment of patients with severe atopic eczema [O] . R. Wang, K. Eyerich, S. Eyerich, 2016

机译：044 IgE特异性免疫吸附治疗严重特应患者的特异性免疫组细胞机制

CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema

著录项

相似文献

相关主题

期刊订阅